Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM1 | P11229 | 1/20 | 0.52 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.52 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.52 |
| ▸ | HTR2A | P28223 | 1/20 | 0.52 |
| ▸ | HTR2C | P28335 | 1/20 | 0.52 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.52 |
| ▸ | HRH1 | P35367 | 1/20 | 0.52 |
| ▸ | DRD3 | P35462 | 1/20 | 0.52 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.52 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.52 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | METAP1 | P53582 | 1/20 | 0.41 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.40 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.40 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.40 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.40 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL905432 | 1.00 | CHRM1 (0.52) | CHRM1AKR1A1CHRM3HTR2AHTR2C | |
| SCHEMBL905429 | 1.00 | CHRM1 (0.52) | CHRM1AKR1A1CHRM3HTR2AHTR2C | |
| SCHEMBL28727671 | 0.97 | CHRM1 (0.50) | CHRM1AKR1A1CHRM3HTR2AHTR2C | |
| Pentane SCHEMBL28232338 | 0.93 | CHRM1 (0.46) | CHRM1AKR1A1CHRM3HTR2AHTR2C | |
| SCHEMBL905445 | 0.85 | CA2 (0.52) | CHRM1AKR1A1CHRM3HTR2AHTR2C | |
| SCHEMBL905447 | 0.85 | CA2 (0.52) | CHRM1AKR1A1CHRM3HTR2AHTR2C | |
| SCHEMBL6157245 | 0.83 | GPR84 (0.54) | GRIK1SLC1A2SLC1A1GRIK2CA2 | |
| SCHEMBL1042654 | 0.81 | GPR84 (0.57) | GRIK1SLC1A2SLC1A1GRIK2ACE2 | |
| SCHEMBL338277 | 0.81 | GPR84 (0.57) | GRIK1SLC1A2SLC1A1GRIK2ACE2 | |
| SCHEMBL2928745 | 0.81 | GPR84 (0.57) | GRIK1SLC1A2SLC1A1GRIK2ACE2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080233621-A1 | Method For Producing Alcohol and Carboxylic Acid Having Optical Activity | API CORPORATION (JP) | 2008-09-25 | — | — | US | claimed |
| EP-1712630-A1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE ALCOHOL AND CARBOXYLIC ACID | API Corporation (JP) | 2006-10-18 | — | — | EP | claimed |
| EP-2278014-A2 | Method for producing alcohol and carboxylic acid having optical activity | API Corporation (JP) | 2011-01-26 | — | — | EP | disclosed |
| EP-2270178-A2 | Method for producing alcohol and carboxylic acid having optical activity | API Corporation (JP) | 2011-01-05 | — | — | EP | disclosed |
| US-7534908-B2 | Method for the production of optically active 3-alkylcarboxylic acids and the intermediate products thereof | WACKER CHEMIE AG (DE) | 2009-05-19 | — | — | US | disclosed |
| US-7534908-B2 | Method for the production of optically active 3-alkylcarboxylic acids and the intermediate products thereof | WACKER CHEMIE AG (DE) | 2009-05-19 | — | — | US | disclosed |
| US-7534908-B2 | Method for the production of optically active 3-alkylcarboxylic acids and the intermediate products thereof | WACKER CHEMIE AG (DE) | 2009-05-19 | — | — | US | disclosed |
| US-20080233621-A1 | Method For Producing Alcohol and Carboxylic Acid Having Optical Activity | API CORPORATION (JP) | 2008-09-25 | — | — | US | disclosed |
| EP-1748975-B1 | METHOD FOR THE PRODUCTION OF OPTICALLY ACTIVE 3-ALKYL CARBOXYLIC ACIDS AND THE INTERMEDIATE PRODUCTS THEREOF | WACKER CHEMIE AG (DE) | 2008-02-13 | — | — | EP | disclosed |
| US-20070225519-A1 | Method for the Production of Optically Active 3-Alkyl Carboxylic Acids and the Intermediate Products Thereof | CONSORTIUM FUER ELEKTROCHEMISCHE INDUSTRIE GMBH (DE) | 2007-09-27 | — | — | US | disclosed |
| US-20070225519-A1 | Method for the Production of Optically Active 3-Alkyl Carboxylic Acids and the Intermediate Products Thereof | CONSORTIUM FUER ELEKTROCHEMISCHE INDUSTRIE GMBH (DE) | 2007-09-27 | — | — | US | disclosed |
| US-20070225519-A1 | Method for the Production of Optically Active 3-Alkyl Carboxylic Acids and the Intermediate Products Thereof | CONSORTIUM FUER ELEKTROCHEMISCHE INDUSTRIE GMBH (DE) | 2007-09-27 | — | — | US | disclosed |
| EP-1712630-A1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE ALCOHOL AND CARBOXYLIC ACID | API Corporation (JP) | 2006-10-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070225519-A1 | Method for the Production of Optically Active 3-Alkyl Carboxylic Acids and the Intermediate Products Thereof | ME1, ME3, ACMSD | CHRM1 1439/4885AKR1A1 392/4885CHRM3 1318/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.